Event Calendar

Mountain View Hospital

3100 N Tenaya Way
Las Vegas, NV 89128

Learning Objectives:

• Explain mechanisms of action (MOAs) for approved and emerging monoclonal antibodies, as well as rationale for choices based on phenotype
• Summarize key efficacy and safety data pertaining to the monoclonal antibodies studied for use in asthma
• Use monoclonal antibodies safely and appropriately in clinical scenarios

Faculty:
Sandra Adams, MD, MS
Professor of Medicine
The University of Texas Health Science Center
San Antonio, TX

Accreditation Statement:
The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
Physicians: The France Foundation designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC point(s) equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Commerical Support:
This educational activity is supported by an educational grant from GlaxoSmithKline.